OpenVSafe by OpenVAERS
Search V-safe

EFR-69373-73369

2 vaccinations 8 coded responses 25 check-ins 8 free-text entries 1 call case
Sex
Male
Age at first dose
66+
ZIP prefix
201 / VA
Registered
2021-01-30
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-30
    Registered in v-safe
  2. 2021-01-30
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-30
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: Paranasal sinus hypersecretion — Feeling: Good
    Free text: sinus drainage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Asthenia, Insomnia — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: I have suffered insomnia the past two nights and to an OTC "sleep aid" each night after hours of non-sleep. the sleep aid left me to weak to get out of bed until Noon, whereas I am usually up, showed and dressed by 4am. I believe recipients should be warned insomnia is a potential side effect and not to drink or take sleep aids. effect .
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Nonspecific reaction, Unevaluable event — Feeling: Good · Fatigue or tiredness
    Free text: vital signs improving.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-06
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-13
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-20
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-20
    Survey response — day 0, dose 2
    MedDRA: Dizziness — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: dizzy for about 2 hours
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  15. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-02-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypotension — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: low BP. 90/45 range
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypotension — Feeling: Good · Fatigue or tiredness
    Free text: low blood pressure. 93/50
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-02-27
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  21. 2021-03-06
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-22
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-22
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-21
    Survey response — 6 months, dose 2
    MedDRA: Heart rate decreased, Hypotension — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Extremely low BP and pulse for about 6 weeks. Pulse >50BP>80/40
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2022-02-22
    Survey response — 12 months, dose 2
    MedDRA: Dysgraphia, Exercise tolerance decreased, Heart rate increased, Heart rate irregular, Lethargy, Memory impairment, Office visit — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Rapid and erratic pulse. It comes and goes without pattern. Lethargy. Greatly reduced endure to any level of physical exertion. Some difficulty remembering names, initially. Some difficulty spelling some words. · Healthcare visit (other): ecco-cariogram and tests. evaluation by my cardiologist.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-02-22
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  30. 2022-02-23
  31. 2022-03-04
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-01-30Pfizer-BioNTech
22021-02-20Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-01-31

Systemic reaction (other): sinus drainage

2021-02-02

Systemic reaction (other): I have suffered insomnia the past two nights and to an OTC "sleep aid" each night after hours of non-sleep. the sleep aid left me to weak to get out of bed until Noon, whereas I am usually up, showed and dressed by 4am. I believe recipients should be warned insomnia is a potential side effect and not to drink or take sleep aids. effect .

2021-02-03

Systemic reaction (other): vital signs improving.

Release 4 — day 0, dose 2

2021-02-20

Systemic reaction (other): dizzy for about 2 hours

Release 4 — days 1–6 daily, dose 2

2021-02-23

Systemic reaction (other): low BP. 90/45 range

2021-02-24

Systemic reaction (other): low blood pressure. 93/50

Release 9 — 6 months, dose 2

2021-08-21

Symptoms: Extremely low BP and pulse for about 6 weeks. Pulse >50BP>80/40

Release 11 — 12 months, dose 2

2022-02-22

Symptoms: Rapid and erratic pulse. It comes and goes without pattern. Lethargy. Greatly reduced endure to any level of physical exertion. Some difficulty remembering names, initially. Some difficulty spelling some words.
Healthcare visit (other): ecco-cariogram and tests. evaluation by my cardiologist.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDDysgraphia · · ✓
SDExercise tolerance decreased · · ✓
SDHeart rate decreased ✓ · ✓
SDHeart rate increased · · ✓
SDHeart rate irregular · · ✓
SDHypotension ✓ · ✓
SDLethargy · · ✓
SDMemory impairment · · ✓
SROAsthenia ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROHypotension ✓ ✓ ✓
SROInsomnia ✓ ✓ ✓
SRONonspecific reaction ✓ ✓ ○
SROParanasal sinus hypersecretion ✓ ✓ ✓
SROUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release